RetractedArticleOncogene2023

Retraction Note: Targeting KDM4A-AS1 represses AR/AR-Vs deubiquitination and enhances enzalutamide response in CRPC.

Boya Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.